Elk Creek Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,089	Closed	-$200K	–	132
2019 Q1	$200K	Sell	1,089 -448	-29%	-$82.7K	0.01%	131
2018 Q4	$255K	Sell	1,537 -2,253	-59%	-$390K	0.02%	128
2018 Q3	$730K	Hold	3,790	–	–	0.04%	125
2018 Q2	$644K	Sell	3,790 -182	-5%	-$28.2K	0.04%	128
2018 Q1	$647K	Buy	3,972 +580	+17%	+$94.7K	0.04%	131
2017 Q4	$508K	Hold	3,392	–	–	0.03%	135
2017 Q3	$516K	Buy	3,392 +272	+9%	+$40.9K	0.03%	133
2017 Q2	$402K	Hold	3,120	–	–	0.03%	136
2017 Q1	$341K	Buy	3,120 +10	+0.3%	+$880	0.02%	139
2016 Q4	$229K	Sell	3,110 -1,247	-29%	-$101K	0.02%	147
2016 Q3	$380K	Sell	4,357 -405	-9%	-$38.3K	0.03%	133
2016 Q2	$410K	Sell	4,762 -6,577	-58%	-$568K	0.03%	130
2016 Q1	$901K	Sell	11,339 -850	-7%	-$76.9K	0.07%	130
2015 Q4	$1.53M	Sell	12,189 -268	-2%	-$32.4K	0.11%	124
2015 Q3	$1.3M	Buy	12,457 +6,251	+101%	+$803K	0.1%	130
2015 Q2	$766K	Sell	6,206 -5,738	-48%	-$723K	0.07%	142
2015 Q1	$1.41M	Hold	11,944	–	–	0.15%	143
2014 Q4	$1.42M	Buy	+11,944	New	+$1.35M	0.18%	139